Literature DB >> 18608706

Confusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins used in aesthetic applications.

Andy Pickett, Stephen Dodd, Berthold Rzany.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18608706     DOI: 10.1080/14764170802094282

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


× No keyword cloud information.
  8 in total

1.  Do complexing proteins provide mechanical protection for botulinum neurotoxins?

Authors:  Dirk Dressler; Lizhen Pan; Fereshte Adib Saberi; Hans Bigalke
Journal:  J Neural Transm (Vienna)       Date:  2019-06-06       Impact factor: 3.575

Review 2.  Facial rejuvenation for middle-aged women: a combined approach with minimally invasive procedures.

Authors:  Alberto Goldman; Uwe Wollina
Journal:  Clin Interv Aging       Date:  2010-09-23       Impact factor: 4.458

3.  Consistent biochemical data are essential for comparability of botulinum toxin type A products.

Authors:  Andy Pickett
Journal:  Drugs R D       Date:  2011

4.  Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?

Authors:  Jürgen Frevert; Dirk Dressler
Journal:  Biologics       Date:  2010-12-09

5.  Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data.

Authors:  Andy Pickett
Journal:  Clin Ophthalmol       Date:  2011-09-09

6.  Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm.

Authors:  Juwan Park; Michael S Lee; Andrew R Harrison
Journal:  Clin Ophthalmol       Date:  2011-06-01

Review 7.  Botulinum toxin type A products are not interchangeable: a review of the evidence.

Authors:  Mitchell F Brin; Charmaine James; John Maltman
Journal:  Biologics       Date:  2014-10-06

8.  Diffusion of botulinum toxins.

Authors:  Matthew A Brodsky; David M Swope; David Grimes
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.